Endpoints News 生物医药· Lei Lei Wu·· 15 天前AI 评分35
Kamau 共享其改良型镰状细胞基因编辑疗法初步临床数据
#ASH26: Kamau shares first data from revamped sickle cell gene editing therapy
AI 导读
Kamau Therapeutics 共享了其改良型镰状细胞基因编辑疗法的初步临床数据。该数据尚未经过同行评审,显示了初步的安全性和有效性。
正文
Kamau Therapeutics, which has stayed relatively quiet since its 2023 emergence, is sharing clinical data from its revamped sickle cell gene editing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news